Mycosis fungoides-type eruptions induced by carbamazepine;Erupciones de tipo micosis fungoide inducidas por carbamazepina

Actas Dermo-Sifiliograficas

Volumn 97, Issue 1, 2006, Pages 43-47

  Álvarez Ruiz, Sara ^a   Delgado, Yolanda ^a   Aragües, Maximiliano ^a   Fraga, Javier ^a   Sánchez Pérez, Javier ^a   Fernández Herrera, Jesús ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Carbamazepine; Mycosis fungoides; Pseudolymphoma

Indexed keywords

CARBAMAZEPINE; CORTICOSTEROID; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; MYCOSIS FUNGOIDES; PATHOLOGY; PSEUDOLYMPHOMA; RASH; SKIN DISEASE; SKIN INFLAMMATION;

EID: 33645035352     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-7310(06)73347-6     Document Type: Article

References (19)

1. Welykyj S, Gradini R, Nakao J, Massa M. Carbamazepine-induced eruption histologically mimicking mycosis fungoides. J Cutan Pathol. 1990;17:111-6.
2. Gul U, Kilic A, Dursun A. Carbamazepine-induced pseudo mycosis fungoides. Ann Pharmacother. 2003;37:1441-3.
3. Saeki H, Etoh T, Toda K, Mihm MC Jr. Pseudolymphoma syndrome due to carbamazepine. J Dermatol. 1999;26:329-31.
4. Shuttleworth D, Graham-Brown RA, Williams AJ, Campbell AC, Sewell H. Pseudo-lymphoma associated with carbamazepine. Clin Exp Dermatol. 1984;9:421-3.
5. Cohen LM, Ugent RB. Linear IgA bullous dermatosis occurring after carbamazepine. J Am Acad Dermatol. 2002;46:32-3.
6. Lee AY, Joo HJ, Chey WY, Kim YG. Photopatch testing in seven cases of photosensitive drug eruptions. Ann Pharmacother. 2001;35:1584-7.
7. Leyva L, Torres MJ, Posadas S, et al. Anticonvulsant-induced toxic epidermal necrolysis: monitoring the immunologic response. J Allergy Clin Immunol. 2000;105:157-65.
8. Lachgar T. Generalized acute exanthematous pustulosis caused by carbamazepine. Allerg Immunol. 1999;31:151-2.
9. Troost RJ, Oranje AP, Lijnen RL, Benner R, Prens EP. Exfoliative dermatitis due to immunologically confirmed carbamazepine hypersensitivity. Pediatr Dermatol. 1996;13:316-20.
10. Fernández Herrera J, Hernández Núñez A. Anticonvulsivantes. Erupciones cutáneas medicamentosas. Barcelona; Signament Edicions, S.L.; 2003. p. 239-48.
11. Callot V, Roujeau JC, Bagot M, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Two different clinical entities. Arch Dermatol. 1996;132:1315-21.
12. Pseudolymphomas of the skin. En: Cerroni L, Gatter K, Kerl H, editors. An illustrated guide to skin lymphoma. 2nd ed. Oxford: Blackwell Publishing. 2004. p. 155-76.
13. Choi TS, Doh KS, Kim SH, Jang MS, Suh KS, Kim ST. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome. Br J Dermatol. 2003;148:730-6.
14. Jones M, Fernández-Herrera J, Dorado JM, Sols M, Ruiz M, García-Díez A. Epicutaneous test in carbamazepine reactions. Dermatology. 1994;188:18-20.
15. Working party of the ESCD for the study of skin testing in investigating cutaneous adverse drug reactions. Guidelines for performing skin test with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45:321-8.
16. Brandy SB, Magro CM, Díaz-Cano SJ, Wolfe HJ. Analysis of clonality of atypical cutaneous lymphoid infiltrates associated with drug therapy by PCR/DGGE. Hum Pathol. 1999;30:130-6.
17. Cogrel O, Beylot-Barry M, Vergier B, et al. Sodium valproate-induced cutaneous pseudolymphoma followed by recurrence with carbamazepine. Br J Dermatol. 2001;144:1235-8.
18. Miranda-Romero A, Pérez-Oliva N, Aragoneses H, et al. Carbamazepine hypersensitivity syndrome mimicking mycoses fungoides. Cutis. 2001;67:47-51.
19. Magro CM, Crowson AN, Kovatich A, Burns F. Drug-induced reversible lymphoid discrasia: a clonal lymphomatoid dermatitis of memory and activated T cells. Hum Pathol. 2003;34:119-29.